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 Retinal pigment epithelial (RPE) cells form a monolayer
between the retina and the choriocapillaris. These cells con-
stitute one aspect of the blood retinal barrier and play a criti-
cal role in the maintenance of the neural retina [1]. They do
not normally divide after birth but may do so in some patho-
logical situations. In proliferative vitreoretinopathy (PVR), for
example, breach of the blood-retinal barrier, accompanied by
a tear in the neural retina that allows vitreous contact with the
RPE cell monolayer, can lead to cell division and epithelial-
mesenchymal transformation (EMT) of the RPE cells. The
resulting fibroblast-like cells can move into the vitreous where
they participate in the formation of a fibrotic epiretinal mem-
brane that may contract, leading to retinal detachment [2]. Risk
factors for PVR include trauma to the eye, contact between
RPE cells and the vitreous, breakdown of the blood-retinal
barrier, and inflammation [3-5]. Gene array analyses of the
changes that occur in cultured RPE cells that have been ex-
posed to vitreous and undergo EMT indicate an inflammatory
or stress response as the cells transform [6] (Ganti et al. In-
vestigative Ophthalmology and Visual Science. In press). The
vitreous-induced changes in gene expression also include in-
creased expression of genes involved in anti-oxidant responses,
such as heme oxygenase-1 (HO-1), metallothioneins (MT),
and hypoxia-induced factor-1 (Ganti et al., In press). Increased
expression of such genes may help to resolve inflammation
and protect the cells from apoptosis.
HO-1 participates in many anti-inflammatory, anti-oxi-
dant and anti-apoptotic responses [7] and is expressed by hu-
man RPE [8-12] and other [7] cells under a variety of condi-
tions. For example, HO-1 expression is increased by such
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Purpose: When human retinal pigment epithelial (RPE) cells come in contact with vitreous, they undergo changes in gene
expression that include inflammatory and anti-oxidant responses. The effects of vitreous on expression of heme oxyge-
nase-1 (HO-1), metallothionein (MT) -1a and -2a, and c-fos were investigated. Activator protein-1 (AP-1) binding sites
are located in the promoter region of HO-1 and MT genes and the effects of vitreous on c-fos activity were investigated.
Methods: Low passage cultures of human RPE cells were grown in the presence or absence of vitreous or transforming
growth factor-β (TGF-β). The expression of HO-1 and MTs was measured by real time PCR and, in the case of HO-1, by
immunoblotting and immunofluorescence microscopy. Specific inhibitors were used to investigate possible signaling
pathways. The effect of vitreous on activation of AP-1 transcription factor was determined by immunoblotting, electro-
phoretic mobility shift assays, or immunofluorescence microscopy.
Results: Incubation of RPE cells with vitreous resulted in increased expression of HO-1, MT-1a and MT-2a. TGF-β
caused an increase in HO-1 expression, although not to the extent mediated by vitreous, but had little effect on MT
expression. Addition of inhibitors of TGF-β signaling (SB431542 or TGF-β-neutralizing antibodies) decreased the vitre-
ous induction of HO-1. Several reactive oxygen species (ROS) quenchers inhibited the TGF-β-induced or vitreous-in-
duced elevation of HO-1 mRNA but had no effect on vitreous-mediated induction of MT expression. Inhibitors of the
mitogen-activated protein kinase (p38MAPK; SB203580) and Jun N-terminal kinase (JNK; SP600125) pathways inhib-
ited vitreous-induction of HO-1. C-fos, a component of AP-1 transcription factor complexes, exhibited increased expres-
sion and activation in the presence of vitreous.
Conclusions: TGF-β, a known component of vitreous, can account for some but not all of the regulation of the anti-
oxidant, anti-inflammatory HO-1 gene in human RPE cells, but it does not participate in the vitreous-mediated upregulation
of MTs. Both vitreous and TGF-β signals increased HO-1 expression via ROS but the latter were not involved in vitreous-
mediated MT expression. Increased p38, JNK, and c-fos activation may be implicated in vitreous modulation of HO-1.
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66stimuli as heavy metals, hypoxia, hyperoxia, inflammation,
and certain growth factors and cytokines, many of which sig-
nal via reactive oxygen species (ROS) generation [7]. MTs
are small proteins containing up to 30% cysteine which bind
metals, particularly zinc, and are powerful anti-oxidants that
may participate in the resolution of inflammation [13]. Since
MTs, like HO-1, are induced in response to oxidative stress
and inflammation, it is not surprising that many of the same
factors control their expression [7,14]. Transforming growth
factor-β (TGF-β) is a growth factor involved in EMT, cell
migration, proliferation, and apoptosis during normal devel-
opment and in certain diseases, including PVR [15]. It is
present in normal vitreous [15] and increases HO-1 expres-
sion in human RPE cells [8].
We investigated the vitreous induction of HO-1 and MT
in low passage human RPE cells. We found that vitreous led
to an increase in HO-1 expression that was partly caused by
TGF-β, and that the rise in HO-1 expression was signaled via
ROS generation. MT-1a and MT-2a were also induced by vit-
reous but their expression was not under the control of TGF-β
or ROS. Concurrent with these changes in anti-oxidant pro-
teins was the activation of c-fos, a component of AP-1 tran-
scription factor complexes that binds to sites in the promoters
of HO-1 [7,16-18], MT-1 [19] and MT-2a [20] genes and which
has been implicated in anti-oxidant and anti-inflammatory re-
sponses.
METHODS
Human vitreous and retinal pigment epithelial cells:  Human
donor eyes were obtained postmortem from Lifepoint (Co-
lumbia, SC) or The Lions’ Eye Bank (Portland, OR). The pro-
tocol adhered to the tenets of the Declaration of Helsinki for
research involving human tissue. The cornea, iris and lens were
removed and the vitreous obtained by inverting the eyecup
and gently squeezing the eye while pulling the vitreous gel
out into a sterile plastic culture dish. RPE cells were isolated
as described previously [21] and cultured in F-10 medium
(Invitrogen, Carlsbad, CA) containing 10% fetal bovine se-
rum (Invitrogen), 1% penicillin-streptomycin-glutamine
(Invitrogen), 1% CaCl2 and 1% ITS culture supplement (BD
Biosciences, San Diego, CA). The RPE cells were used at
passages 3-7 when their morphology remained epithelioid. The
epithelial nature of the cells was confirmed by staining for
keratin [22-24].
Treatment with vitreous:  The vitreous gel was shredded
using a syringe, diluted by adding 3 parts of the above culture
medium to 1 part of vitreous and filtered using a 0.22 µm
polyethersulfone filter bottle (Corning, Corning, NY). The
medium was removed from subconfluent RPE cells that were
then treated with 25% vitreous in complete medium, or fresh
complete medium, for various times. The cells were
subconfluent at the time of treatment and were still
subconfluent at the time of RNA or nuclear protein extrac-
tion.
In some experiments, medium or vitreous-containing me-
dium was supplemented with TGF-β1 (R&D Systems, Min-
neapolis, MN), SB431542, a TGF-beta type I receptor antago-
nist [25] (Tocris Bioscience, Ellisville, MO), neutralizing pan-
specific anti-TGF-β antibody (R&D Systems). ROS genera-
tion was inhibited by N-acetyl cysteine (Sigma-Aldrich, St
Louis, MO), catalase (Sigma-Aldrich), taurine (Sigma-
Aldrich) or dimethyl sulfoxide (Sigma-Aldrich). The extra-
cellular signal-regulated kinases (ERK), c-jun-N-terminal ki-
nases (JNK), p38 MAPK and phosphatidylinositol 3'-kinase
(PI3) kinase were inhibited by PD98059 (Calbiochem, San
Diego, CA), SP600125 (Sigma-Aldrich), SB203580
(Calbiochem), and LY294002 (Sigma-Aldrich), respectively.
RNA extraction, reverse transcription, and real-time quan-
titative PCR:  RNA was extracted using the RNeasy kit
(Qiagen, Valencia, CA) and treated with DNase on the col-
umn. Reverse transcription was carried out with 1 µg total
RNA per 20 µl reaction using the iScript cDNA Synthesis Kit
(Bio-Rad, Hercules, CA) and simultaneous priming with both
random hexamers and oligo (dT); Ganti et al., In press. After
reverse transcription, the reactions were diluted to 300 µl.
“Negative-control” reactions without reverse transcriptase
were carried out to ensure that the results were RNA depen-
dent. Real-time quantitative PCR (qPCR) was performed in
25 µl reactions using iQ SYBR Green Supermix (Biorad) with
1 µM of the appropriate primers, and 5 µl of diluted cDNA
The PCR products were detected using an IQ Real Time PCR
iCycler (Bio-Rad). PCR primers were designed using Oligo 6
(Molecular Biology Insights, Cascade, CO) and are listed in
Table 1. Expression of ribosomal protein, large, P0 (RPLP0)
mRNA was used as an internal standard (normalization/load-
ing control). The ratio of target gene mRNA expression in
treated versus untreated cells was determined according to the
method of Pfaffl et al. using the Real-time Expression Soft-
ware Tool for Excel (REST-XL) version 2 [26,27]. This method
determines the changes in the target gene expression relative
to changes in the internal standard (RPLP0) and corrects for
differences between the efficiencies of the different primer
pairs (for efficiencies, see Table 1). The software applies a
randomization test (2000 randomizations) to determine statis-
tical significance of the results. Use of REST-XL analysis in
the non-normalized mode showed that levels of RPLP0 gene
expression did not vary significantly between control and vit-
reous-treated cells. Each qPCR assay was performed in quin-
tuplicate, and the experiment was repeated at least three times
with different RPE cell/vitreous donors.
Western blotting:  Cells were washed with ice cold PBS
and lysed with a protein extraction buffer (25 mM HEPES pH
7.5, 100 mM NaCl, 10% glycerol, 1% Triton X100, 50 mM
NaF, 1 µM sodium metavanadate, 20 µl protease inhibitor
cocktail/ml [Pierce]). SDS-PAGE was carried out using 4-15%
acrylamide Criterion pre-cast gels (Bio-Rad) and blotted onto
Immun-Blot PVDF membranes (Bio-Rad). Antibodies used
were: rabbit polyclonal anti-HO-1 (Stressgen, Ann Arbor, MI;
SPA-896), goat polyclonal anti-tubulin (Santa Cruz Biotech-
nology, Santa Cruz, CA; SC-9935), and rabbit polyclonal anti-
human c-Fos (Santa Cruz; SC7202x). Alkaline phosphatase-
conjugated secondary antibodies were used together with CDP
Star chemiluminescence detection reagent (Perkin Elmer Life
Science, Boston, MA).
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67Immunofluorescence microscopy:  RPE cells were grown
on sterile glass cover slips in six-well plates. They were washed
with ice cold PBS, fixed with 4% paraformaldehyde, quenched
with 10 mM NH4Cl in PBS, permeabilized with 0.1% Triton
X100 in PBS, incubated with primary antibody in PBS with 5
mg BSA/ml overnight at 4 °C. The cells were then washed
with PBS/BSA, incubated with Oregon Green-488 conjugated
anti-rabbit IgG secondary antibody or a Texas-Red anti-goat
IgG secondary antibody (Molecular Probes, Eugene, OR) for
1 h at 37 °C, and imaged using a Zeiss Metaphor confocal
fluorescence microscope.
Nuclear extracts:  Nuclear extracts were made using a kit
according to the manufacturer’s instructions (Active Motif,
Carlsbad, CA). For experiments involving phosphatase
treatment,we prepared nuclear protein extracts using a kit that
contained phosphatase inhibitor-free solutions (Panomics,
Freemont, CA).
Electrophoretic mobility shift assay:  Electrophoretic mo-
bility shift assays (EMSA) were carried out using EMSA “Gel-
Shift” (Panomics) according to the manufacturer’s instructions.
Nuclear extracts were incubated with a biotin-labeled oligo-
nucleotide containing the consensus binding sequence for AP-
1 (5'-CGC TTG ATG ACT CAG CCG GAA-3') for 30 min at
15 °C, and transcription factor-bound oligonucleotide was
separated from unbound oligonucleotide by electrophoresis
on a 5% polyacrylamide gel. After transfer to Biodyne B ny-
lon membrane (Pall Corporation, Ann Arbor, MI) using a semi-
dry blot apparatus (Bio-Rad), the biotin-labeled bands were
visualized using horseradish peroxidase-based chemilumines-
cence. The image was captured with a Kodak Image station
440 CF. The specificity of binding was verified using unla-
beled consensus oligonucleotide corresponding to AP-1 bind-
ing sequence as a competitor in the binding reaction. To verify
further the identity of the transcription factor bound to the
oligonucleotide, supershift assays were carried out using
polyclonal rabbit anti-human c-fos (TransCruz; sc-7202x,
Santa Cruz). The reaction mixture was incubated for 1 h at 20
°C with 2 µl of the antibody.
RESULTS
Cultured human retinal pigment epithelial cells increase ex-
pression of heme oxygenase-1, metallothionein-1, and -2 when
exposed to vitreous:  In previous work, cultured human RPE
cells were exposed to 25% vitreous in serum-containing me-
dium for various periods of time up to 48 h and mRNA ex-
pression was examined using gene arrays (21,318 genes) for
three independent RPE donor/vitreous donor pairs (Ganti et
al., In press). Genes associated with inflammation and stress,
including interleukin-1β (IL-1β), microsomal prostaglandin
E synthase (mPGES), and cycloöxygenase-2 (COX-2) were
significantly overrepresented among the genes induced by vit-
reous compared to their representation in the total genes on
the arrays. Vitreous treatment also resulted in increased ex-
pression of mRNAs encoding a number of anti-oxidant pro-
teins, including HO-1 and MT-1E. We have previously shown
that human RPE cells express MT-1a and MT-2a [14]; how-
ever, neither of these genes was represented on the microarrays.
Changes in mRNA expression of some anti-oxidant genes
were examined by qPCR. Multiple RPE cell and vitreous do-
nors were used in these experiments. HO-1 mRNA expres-
sion rose by 3 h after contact with vitreous and reached a pla-
teau after 6 h with a mean increase of approximately 11 fold
over the control cells in normal medium without vitreous (Fig-
ure 1). Expression of MT-1a and MT-2a mRNAs was also in-
creased (to a level of five and sevenfold over controls, respec-
tively; Figure 2). The expression of the mRNAs for two other
anti-oxidant enzymes (catalase and Cu/Zn superoxide
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TABLE 1. PRIMERS USED FOR QPCR
       Gene               Primers (5'-3')
-------------------   ------------------------
Heme oxygenase 1      F: GTCCGCAACCCGACAGCA
(HO-1)                R: TCCTCCAGGGCCACATAGATG
Metallothionein 1a    F: GCGCCTTATAGCCTCTCAAC
(MT1a)                R: CAAGTTTGTGCAGGTCACTCT
Metallothionein 2a    F: ACTCTAGCCGCCTCTTCAG
(MT2a)                R: AAGTCGCGTTCTTTACATCTG
Normalization gene:   F: TTAAACCCCCTCGTGGCAATC
Ribosomal protein,    R: CCACATTCCCCCGGATATGA
large, P0 (RPLP0)
F represents forward primer; R represents reverse primer.
Figure 1. Expression of heme oxygenase-1 mRNA in vitreous-treated
retinal pigment epithelial cells.  Low passage donor retinal pigment
epithelial (RPE) cells were incubated with or without vitreous for up
to 24 h. RNA was extracted at each time point and heme oxygenase-
1 (HO-1) mRNA was measured by qPCR. Ribosomal protein, large,
P0 (RPLP0) was used as an internal standard to correct for small
differences in the amount of cDNA used in each reaction. Each point
at a particular time indicates a different RPE/vitreous donor pair. The
number of donor/vitreous pairs examined at each time point is shown.
At 6, 12, and 24 h, REST-XL analysis indicated that HO-1 mRNA
was significantly increased (p<0.05) in vitreous-treated RPE cells
compared to cells in vitreous-free medium.
68dismutase [SOD1]) did not change significantly in most do-
nors when examined by microarray or qPCR analysis (data
not shown).
Vitreous increases heme oxygenase-1 protein levels:  An
increase in HO-1 protein in the presence of vitreous after 6,
12, and 24 h (Figure 3A) was observed by immunoblotting.
The absence of any detectable change in HO-1 at 3 h of treat-
ment was consistent with the observation that vitreous has little
effect on mRNA levels at this time point (Figure 1). A vitre-
ous-induced increase in HO-1 protein was confirmed by im-
munofluorescence microscopy (Figure 3B).
Transforming growth factor-β increases expression of
heme oxygenase-1 but not metallothioneins:  TGF-β
upregulates anti-oxidant and anti-inflammatory proteins in
human RPE [8] and other [28-30] cells. We therefore investi-
gated whether it controls HO-1 and MT mRNA expression.
Incubation of RPE cells with TGF-β1 increased the expres-
sion of HO-1 mRNA (Figure 4A). However, as the concentra-
tion of TGF-β1 was increased, the level of HO-1 mRNA ex-
pression reached a plateau that was usually much lower than
that seen with 25% vitreous, suggesting that if TGF-β in vit-
reous were responsible for the effect on HO-1 mRNA expres-
sion, it was not the only factor. Immunoblotting also indicated
that TGF-β1 induced HO-1 protein, but not to the extent shown
by vitreous (Figure 4B). TGF-β1 did not increase expression
of MT-1a or MT-2a mRNA when added to control medium
and did not cause any increased expression compared to vitre-
ous alone if added to medium containing vitreous (Figure 4C).
Inhibitors of transforming growth factor-β signaling re-
duce vitreous-induced expression of heme oxygenase-1 mRNA:
To determine if TGF-β plays a role in the vitreous-induced
increase in HO-1 mRNA expression, cells were incubated with
vitreous, and TGF-β signaling was inhibited by addition of
SB431542 (10 µM), a TGF-β type I receptor antagonist [25],
or neutralizing pan-specific anti-TGF-β antibody. SB431542
inhibited the vitreous-induced expression of HO-1 mRNA by
about 60% (Figure 5). Increasing the concentration of
SB431542 did not increase the degree of inhibition of HO-1
expression (data not shown). Pan specific TGF-β antibody also
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Figure 2. Expression of metallothionein mRNAs in vitreous-treated
retinal pigment epithelial cells.  Retinal pigment epithelial (RPE)
cells were incubated with or without vitreous for up to 48 h. RNA
was extracted at each time point and RNAs for metallothionein-1a
(MT-1a; quadrangle) and metallothionein-2a (MT-2a; diamond) were
measured by qPCR. Ribosomal protein, large, P0 (RPLP0) was used
as an internal standard to control for small differences in the amount
of cDNA used in each reaction. Each point at a particular treatment
time indicates a different RPE/vitreous donor pair. The number of
donor/vitreous pairs examined at each time point is shown. At all
time points, REST-XL analysis indicated that MT-1 and MT-2a
mRNAs were significantly increased (p<0.01) in vitreous-treated RPE
cells compared to cells in vitreous-free medium.
Figure 3. Expression of heme oxygenase-1 protein in vitreous-treated
retinal pigment epithelial cells.  A: Retinal pigment epithelial (RPE)
cells were incubated with control medium (C) or vitreous-containing
medium (V) for various times. The cells were washed, and proteins
were extracted. The proteins were analyzed by immunoblotting us-
ing rabbit anti-heme oxygenase-1 or mouse anti-tubulin antibodies.
Lanes 1 and 2: 3 h incubation. Lanes 3 and 4: 6 h incubation. Lanes
5 and 6: 12 h incubation. Lanes 7 and 8: 24 h incubation. M repre-
sents molecular weight markers. B: Cells were incubated with con-
trol or vitreous-containing medium for 15 (C15,V15) or 23 h
(C23,V23). They were then fixed, permeabilized, and incubated with
rabbit anti-HO-1 antibody followed by Texas red-conjugated goat
anti-rabbit IgG.
69caused a decrease in vitreous-stimulated HO-1 mRNA expres-
sion by about 50% (Figure 5). Neither SB431542 nor neutral-
izing TGF-β antibody affected MT-1a or MT-2a mRNA ex-
pression (data not shown).
The vitreous-induced increase in heme oxygenase-1 mRNA
expression but not metallothionein mRNA expression is medi-
ated through reactive oxygen species generation:  ROS have
been implicated in upregulation of HO-1 and have been shown
to be involved in some of the effects of TGF-β [31,32]. To
determine whether TGF-β1- or vitreous-mediated upregulation
of gene expression could involve ROS signaling, we incu-
bated TGF-β1- or vitreous-treated RPE cells with or without
N-acetyl cysteine (NAC), a glutathione analog that quenches
ROS. The TGF-β-mediated rise in HO-1 mRNA expression
was completely inhibited by NAC (Figure 6A). NAC also sup-
pressed the vitreous-mediated rise in HO-1 mRNA expres-
sion, sometimes, though not always, to a level of 100% (Fig-
ure 6A).
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Figure 4. Effect of transforming growth factor-β1 on expression of
heme oxygenase-1 and metallothioneins in retinal pigment epithelial
cells.  A: Retinal pigment epithelial (RPE) cells of the same donor
and passage were incubated in control medium or with 25% vitreous
or various concentrations (0.5 -10 ng/ml) of transforming growth
factor-β1 (TGF-β1) for 12 h. Heme oxygenase-1 (HO-1) mRNA levels
in vitreous- or TGF-β1-treated cells compared to control cells were
measured by qPCR using ribosomal protein, large, P0 (RPLP0)
mRNA levels to correct for any differences in the amount of cDNA.
Bar 1: 0.5 ng TGF-β. Bar 2: 1 ng/ml. Bar 3: 5 ng/ml. Bar 4: 10 ng/ml.
Bar 5: 25% vitreous. Values show the change in mRNA expression
compared to control (no change =1). Asterisk (*) indicates that REST-
XL analysis showed a change that is significantly different from con-
trol (p<0.05). B: RPE cells were incubated with normal medium (C),
vitreous-containing medium for 24 h (V), TGF-β1 (5 ng/ml)-con-
taining medium (T) for 24 h, or hemin-containing medium (H) for
24 h as a positive control. The proteins were analyzed by
immunoblotting using rabbit anti-HO-1 antibodies. C: RPE cells were
incubated with 25% vitreous (bars 1, 4) or 1 ng TGF-β1 per ml me-
dium (bars 2, 5) or vitreous and TGF-β combined (bars 3, 6) for 12 h.
mRNA for MT-1a (bars 1, 2, 3) and MT-2a (bars 4, 5, 6) in treated
cells relative to untreated, control cells was determined. Asterisk (*)
indicates that REST-XL analysis showed a change that is signifi-
cantly different from control (p<0.05).
Figure 5. Inhibition of transforming growth factor-β signaling re-
duces the vitreous-mediated increase in heme oxygenase-1 expres-
sion by retinal pigment epithelial cells.  A: Retinal pigment epithe-
lial (RPE) cells were incubated for 12 h in vitreous-containing me-
dium (bar 1) or in the same medium supplemented with SB431542
(10 µM), an inhibitor of type I TGF-β receptor signaling (bar 2).
Heme oxygenase-1 (HO-1) mRNA expression was measured by
qPCR. B: RPE cells were incubated in vitreous-containing medium
(bar 1) or in the same medium supplemented with pan anti-trans-
forming growth factor-β neutralizing antibody (10 µg/ml). HO-1
mRNA expression was measured by qPCR. Values show the change
in mRNA expression compared to control (no change=1). Asterisk
(*) indicates that REST-XL analysis showed a change that is signifi-
cantly different from control levels of HO-1 mRNA (p<0.05). Double
asterisk (**) denotes a value significantly different from the level of
HO-1 mRNA in vitreous-treated cells (p<0.05).
70NAC has been widely used to investigate whether ROS
participate in a number of signaling pathways, including that
initiated by TGF-β [33,34]. However, it has recently been
shown that this inhibitor can act directly on TGF-β by reduc-
ing disulfide bonds, thereby inactivating it [35]. We therefore
used several other quenchers of ROS (DMSO, taurine and cata-
lase) that do not have the potential for disrupting disulfide
bridges. Catalase and DMSO significantly inhibited the vitre-
ous-mediated rise in HO-1 mRNA. The apparent inhibition
by taurine was not statistically significant (Figure 6B). NAC
had no effect on the vitreous-mediated rise in MT-1 or MT-2
expression (Figure 7).
Vitreous induces heme oxygenase-1 mRNA expression via
the activation of mitogen activated protein kinase pathways:
MAPK pathways are frequently implicated in the signaling of
HO-1 expression [7]. These consist of cascades of serine/threo-
nine kinases, which sequentially phosphorylate and activate
each other and target many transcription factors. The ERK,
JNK, and p38 MAPK pathways have been intensively stud-
ied. JNK and p38 have been implicated in TGF-β signaling
[36].
Inhibition of the ERK pathway with PD98059 (50 µM)
had no effect on the vitreous-mediated rise in HO-1 (Figure
8), MT-1a or MT-2a mRNAs (data not shown). Others have
observed a lack of participation of this pathway in ROS-me-
diated upregulation of HO-1 expression [16]. As a positive
control, we examined vitreous-induced expression of COX-2
mRNA and found that this was partly inhibited by PD98059
(data not shown). Inhibition of the PI3-kinase pathway by
LY294002 (50 µM) also had no effect on the vitreous-induced
increase in HO-1 mRNA (Figure 8) but, again, the vitreous-
mediated increase in COX-2 expression was inhibited (data
not shown). Addition of SB203580 (10 µM), which inhibits
the α and β isoforms of p38 MAPK [37,38], resulted in ap-
proximately 50% inhibition of HO-1 mRNA induction. Inhi-
bition of JNK by SP600125 (10 µM) also resulted in partial
©2007 Molecular Vision Molecular Vision 2007; 13:66-78 <http://www.molvis.org/molvis/v13/a8/>
Figure 6. Reactive oxygen species quenchers inhibit the vitreous-
mediated and transforming growth factor-β-mediated increase in heme
oxygenase-1 mRNA expression.  A: Retinal pigment epithelial (RPE)
cells were incubated with control medium, vitreous-containing me-
dium (VIT) or TGF-β1 (1 ng/ml)-containing medium for 12 h with
or without 2 mM N-acetyl cysteine (NAC). HO-1 mRNA was mea-
sured by qPCR. All ratios are compared to the level in cells in con-
trol medium. B: RPE cells were incubated for 12 h in control me-
dium, vitreous-containing medium (VIT) or vitreous-containing
medium supplemented with 200 units catalase (VIT/CAT) per ml, 40
mM taurine (VIT/TAU) or 250 µM DMSO (VIT/DM). HO-1 mRNA
was measured by qPCR. All ratios are relative to the level in cells in
control medium (no change = ratio of 1.0). Asterisk (*) indicates that
REST-XL analysis showed a change that is significantly different
from control (p<0.05). Double asterisk (**) indicates a value signifi-
cantly different from the level of HO-1 mRNA in vitreous-treated
cells (p<0.05).
Figure 7. N-acetyl cysteine has no effect on the vitreous-mediated
change in metallothionein expression.  Cells were incubated with
vitreous for 12 h with or without 2 mM N-acetyl cysteine (NAC).
RNA was extracted and metallothionein-1 (MT-1) and
metallothionein-2a (MT-2a) mRNA expression was measured by
qPCR. Ratios show the change in mRNA expression compared to
control (no change=ratio of 1). Asterisk (*) indicates that REST-XL
analysis revealed a change that is significantly different from control
(p<0.05).
71inhibition of HO-1 mRNA induction (Figure 8).
Vitreous leads to the activation of AP-1/c-fos:  Our re-
sults showed that vitreous increased HO-1 expression, at least
in part, by TGF-β signaling and by ROS generation. The sig-
naling pathways may also include p38 and JNK MAPKs, both
of which have been implicated in TGF-β signaling [36]. TGF-
β modulation of many genes is dependent on AP-1 binding
sites in their promoters [39-41]. Such transcription factor bind-
ing sites have been reported in the promoters of human and
mouse HO-1 genes; moreover, these sites can participate in
ROS activation of HO-1 gene transcription [18,42-44]. Tran-
scription factors that bind to AP-1 sites include c-jun/c-fos
heterodimers [45] and these are potential targets of JNK and
p38 MAPK pathways. We therefore investigated whether vit-
reous can activate AP-1 transcription factors, which might
implicate them in the vitreous-mediated anti-oxidant response.
EMSA analyses showed that, compared to controls,
nuclear extracts from RPE cells treated with vitreous for 1 h
had increased protein binding activity for the AP-1 consensus
sequence (arrow; Figure 9, compare lane 3 with lane 6). Addi-
tion of unlabeled AP-1 consensus sequence to the reaction
decreased the intensity of the band formed by labeled AP-1
consensus sequence and AP-1 binding protein (arrow; Figure
9, lanes 4 and 7). To determine whether c-fos was part of the
complex that bound to AP-1 binding sites after vitreous treat-
ment, we carried out supershift assays. These indicated that c-
fos was a component of the protein complex binding to the
AP-1 consensus sequence. The protein-DNA band seen in the
absence of c-fos antibody (Figure 9, lanes 3 and 6) was de-
creased in intensity when c-fos antibody was added (arrow;
Figure 9, lanes 5 and 8), but a super-shifted DNA-protein-
antibody band was not detected, possibly because the protein-
DNA-antibody complex did not enter the gel.
Vitreous increases c-fos mRNA and protein expression:
C-fos is an early response protein that is activated by phos-
phorylation [45]. Activation is sometimes accompanied by
increased expression at the transcriptional level [46]. We used
qPCR to determine the levels of c-fos mRNA after treatment
with vitreous for various times. Multiple RPE cell and vitre-
ous donors were used in these experiments. For all time points,
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Figure 8. Inhibitors of p38 mitogen-activated protein kinase and Jun
N-terminal kinase but not of extracellular signal-regulated kinase 1/
2 or PI3 kinase inhibit the vitreous-mediated expression of heme
oxygenase-1 mRNA.  A: Cells were incubated for 12 h with control
medium, 25% vitreous or 25% vitreous supplemented with 10 µM
SB203580 which inhibits p38 mitogen-activated protein kinase
(MAPK). RNA was extracted and heme oxygenase-1 (HO-1) mRNA
was measured by qPCR. B: Cells were incubated for 12 h with con-
trol medium, 25% vitreous or 25% vitreous supplemented with 50
µM PD98059, which inhibits ERK1/2. C: Cells were incubated for
12 h with control medium, 25% vitreous or 25% vitreous supple-
mented with 50 µM LY294002, D: Cells were incubated for 12 h
with control medium, 25% vitreous or 25% vitreous supplemented
with 10 µM SP600125, which inhibits Jun N-terminal kinase (JNK).
Ratios show the change in mRNA expression compared to control
(no change equal to ratio of 1). Asterisk (*) indicates that REST-XL
analysis showed a change that is significantly different from control
levels of HO-1 mRNA (p<0.05). Double asterisk (**) denotes a value
significantly different from the level of HO-1 mRNA in vitreous-
treated cells (p<0.05).
Figure 9. Vitreous activates AP-1 transcription factor.  Nuclear pro-
tein extracts from control retinal pigment epithelial (RPE) cells or
RPE cells treated with vitreous for one hour were incubated with a
biotin-labeled probe, corresponding to the consensus binding se-
quence for AP-1. The probe-transcription factor complexes were sepa-
rated from an unbound probe on a 5% polyacrylamide gel, trans-
ferred to nylon membranes, and detected by chemiluminescence. 1
represents labeled probe only; 2 represents labeled probe + anti-c-
fos antibody; 3 represents control nuclear protein extract + labeled
probe; 4 represents control nuclear protein extract + labeled probe +
unlabeled probe; 5 represents control nuclear protein extract + la-
beled probe + anti-c-fos antibody; 6 represents vitreous-treated cell
nuclear protein extract + labeled probe; 7 represents vitreous-treated
cell nuclear protein extract + labeled probe + unlabeled probe; and 8
represents vitreous-treated cell nuclear protein extract + labeled probe
+ anti-c-fos antibody. The arrow indicates the position of the probe/
AP-1 complex.
72cells were incubated with fresh complete medium or medium
containing 25% vitreous for the same length of time. Com-
pared to controls, significantly increased levels of c-fos mRNA
(Figure 10, average = 11 fold, p<0.004) were found in RPE
cells after 30 min of treatment with vitreous. After 1, 3, 6, 12,
and 24 h of vitreous treatment, the levels of c-fos mRNA de-
creased compared to levels at 30 min and were not signifi-
cantly higher than those of control cells.
Nuclear protein extracts from control RPE cells or cells
treated with vitreous for one hour were examined for expres-
sion of c-fos protein. Vitreous treatment resulted in increased
expression (about four to fourteen fold) of c-fos protein, mi-
grating at about 62 kDa, compared to the amounts of c-fos in
the nuclear protein extracts from control cells (Figure 11A,
arrow, and Figure 11B).
C-fos protein is activated by phosphorylation in retinal
pigment epithelial cells after vitreous treatment:  Phosphory-
lation is one mechanism that increases the stability of c-fos
protein [47]. Therefore, nuclear protein extracts from cells
treated for 1 h with control medium or vitreous-containing
medium were incubated with lambda protein phosphatase,
which is active toward phosphorylated serine, threonine, and
tyrosine residues. When electrophoretically separated, migra-
tion of c-fos in phosphatase-treated samples was faster indi-
cating loss of phosphorylation (Figure 11C, compare lane 2 to
lane 1 and lane 4 to lane 3). The c-fos present in nuclear pro-
tein extracts of both vitreous-treated and control RPE cells
was found to be sensitive to phosphatase treatment (Figure
11C, lanes 2 and 4).
C-fos protein moves into the nucleus on vitreous treat-
ment:  RPE cells were stained for c-fos protein after treating
with control or vitreous-containing medium for various times
and examined by immunofluorescence confocal microscopy.
At 30 min, c-fos was visible in the nucleus and the cytoplasm.
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Figure 10. Vitreous increases c-fos mRNA levels in retinal pigment
epithelial cells.  Retinal pigment epithelial (RPE) cells were treated
for various times with control medium or vitreous-containing me-
dium, and the levels of mRNA for c-fos were measured using qPCR.
Each point at a particular treatment time indicates a different RPE/
vitreous donor pair, and the number of donor/vitreous pairs is shown.
At 30 min, REST-XL analysis showed that c-fos mRNA was signifi-
cantly increased (*p<0.004) in vitreous-treated RPE cells.
Figure 11. Vitreous increases c-fos protein expression and phospho-
rylation.  A: Retinal pigment epithelial (RPE) cells were treated with
25% vitreous for one hour. Nuclear proteins were extracted and sub-
jected to SDS-polyacrylamide gel electrophoresis and immunoblot
analysis. Lanes 1A, 1B: Control nuclear protein extract. Lanes 2A,
2B: Nuclear protein extract from vitreous-treated RPE cells. Data
shown are from two different RPE-vitreous donor pairs (A and B).
The position of the c-fos band (62 kDa) is indicated by the arrow. B:
Intensities of chemiluminescence corresponding to the bands at about
62 kDa in Figure 11A. A 4.3 fold (lane 2A compared to lane 1A) and
11.1 fold (lane 2B compared lane 1B) increase in c-fos protein was
seen in the nuclear protein extracts of vitreous-treated RPE cells. C:
RPE cells were treated with 25% vitreous for one hour. Nuclear pro-
teins were extracted and treated with or without lambda protein phos-
phatase. Phosphatase (p’ase) treatment (+) resulted in the band at the
position of c-fos moving faster in both control (lane 2) and vitreous-
treated (lane 4) RPE nuclear protein extracts compared to
nonphosphatase treated (-) samples (lanes 1, 3).
73There was a small increase in nuclear c-fos in vitreous-treated
(Figure 12B) compared to control RPE cells (Figure 12A).
The level of c-fos staining in control cells did not change
after 1, 2, or 3 h treatment with fresh complete medium (data
not shown). However, vitreous-treated RPE cells showed in-
creased staining for c-fos at these time points, confirming in-
creased expression at the protein level. In addition, the pro-
tein moved into the nucleus after 1 (Figure 12C), 2 (Figure
12D), or 3 (Figure 12E) h of treatment. Controls in which
only secondary antibody was used did not show any staining
(Figure 12F).
DISCUSSION
 Vitreous has a profound influence on human RPE cells, caus-
ing them to acquire fibroblast-like characteristics in cell cul-
ture [48]. This EMT is similar to that which occurs in vivo in
PVR [15,49]. Vitreous also stimulates RPE cells to express
proteins associated with an inflammatory response; for ex-
ample, the expression of IL-1β, COX-2, and mPGES is in-
creased [21] (Ganti et al., In press). Increased oxidative stress
is a frequent component of inflammatory disease, including
in the eye [50], and subsequently provokes an anti-inflamma-
tory, anti-oxidant response. Thus, proinflammatory cytokines
such as TNF-α, upregulate antioxidant proteins, including HO-
1 and MTs, as part of the resolution phase of inflammation
[51]. Preinduction of HO-1 [52] or MTs [14] can ameliorate
inflammation and protect against apoptosis and oxidative in-
jury [12,51,53-59]. The observation that vitreous-treated RPE
cells in culture express enhanced levels of HO-1, MT-1a, and
MT-2a is consistent with these proteins being induced as part
of a protective response against stress and inflammatory me-
diators.
There are several isoforms of HO. HO-1 is the inducible
form [7]. This enzyme catalyzes the breakdown of heme to
iron, biliverdin, and carbon monoxide. Biliverdin is then re-
duced to bilirubin (a powerful anti-oxidant) while iron (a pro-
oxidant) is sequestered by ferritin [7]. Several genes encode
MTs in a tissue-specific manner but most commonly expressed
are MT1 and MT2 of which there are several isoforms [54].
These small multifunctional cysteine-rich proteins act as anti-
oxidants by scavenging oxygen and hydroxyl radicals and as
anti-apoptotic agents by inhibiting caspase-3 activation [54].
HO-1 expression is elevated during inflammation resulting
from the expression of proinflammatory cytokines (including
TNF-α, interleukins 1α, 1β, 6, 8, 12, and 18 and interferon-γ)
[60-62] and many of the same cytokines also up regulate MT
expression [14,63]. Subsequently, carbon monoxide, a prod-
uct of HO-1 activity, suppresses the synthesis of
proinflammatory cytokines, nitric oxide, and prostaglandins
[55-57] and the use of MT knockout mice suggests a similar
function for MTs [58,59]. Thus, these proteins provide a nega-
tive feedback during inflammation that inhibits oxidative dam-
age [53].
The importance of HO-1 and MT as anti-inflammatory
agents led us to investigate the components of vitreous that
may control anti-oxidant gene expression. Although vitreous
comprises mainly collagen and water, it contains a number of
other proteins in smaller amounts, among which are many
growth factors. Many of these vitreous constituents are not
well characterized, and it is unlikely that a single stimulatory
molecule is responsible for the induction of HO-1 and MTs;
more probable is a complex interaction between multiple fac-
tors that act synergistically to promote an anti-oxidant response.
One well characterized vitreous protein, however, is TGF-β,
which has been implicated in PVR [15] and in EMT responses
in general [64]. This growth factor induces HO-1 in RPE cells
[8] and many other cell types [7]. Thus, we examined the role
of TGF-β in the anti-oxidant response using inhibitors of TGF-
β signaling.
When TGF-β binds to the TGF-β receptor (TGF-βR), the
TGF-βR type II component phosphorylates the TGF-βR type
I component, activating its kinase activity and leading to fur-
ther phosphorylation signaling events, including the activa-
tion of smad 2 and 3 transcription factors [65]. SB431542 is a
TGF-βR type I antagonist [25], which substantially inhibits
©2007 Molecular Vision Molecular Vision 2007; 13:66-78 <http://www.molvis.org/molvis/v13/a8/>
Figure 12. C-fos protein is increased in expression and moves into
the nucleus of vitreous-treated retinal pigment epithelial cells.  Reti-
nal pigment epithelial (RPE) cells were treated with control medium
or vitreous-containing medium for various periods of time. At 30
min, the control (A) and vitreous-treated (B) RPE cells had a similar
pattern of staining for c-fos. The pattern of immunostaining remained
the same for control cells at 1, 2, and 3 h (data not shown). Vitreous-
treated RPE cells at 1, 2, and 3 h (C, D, E) showed intense staining
for c-fos in the nucleus. F: Staining with secondary antibody only.
74vitreous-mediated upregulation of HO-1, as does a panspecific
anti-TGF-β neutralizing antibody. This implies that a TGF-β-
dependent pathway plays an important role in the induction of
HO-1. The fact that neither inhibitor reduces the increase in
expression of HO-1 by more than 60% suggests that other
pathways are also involved. This is not surprising since HO-1
mRNA expression can be controlled by multiple pathways at
both the transcriptional and post-transcriptional levels [7].
Neither SB431542 nor the neutralizing antibody had any ef-
fect on vitreous-mediated MT1a or MT2a mRNA expression
and thus vitreous factors other than TGF-β are responsible for
MT mRNA induction. Moreover, TGF-β added to RPE cells,
while inducing HO-1, had no effect on MT mRNA expression
as measured by qPCR, although we previously found a weak
response in RPE cells measured by Northern blotting [14].
TGF-β added to RPE cells did not induce HO-1 to the level
that would have been expected, given the effect of TGF-β in-
hibitors on vitreous-induction of HO-1. This could be because
there are factors in vitreous that act synergistically to increase
signaling via the TGF-β-dependent pathway.
HO-1 gene expression is frequently induced by ROS [7]
and TGF-β can signal via ROS generation [66-68]. It was there-
fore possible that vitreous could induce changes in expression
of HO-1 genes via ROS generation. Several ROS quenchers
decreased vitreous-mediated HO-1 mRNA expression. NAC
is a glutathione analog and ROS scavenger and usually com-
pletely suppressed HO-1 upregulation by vitreous or TGF-β,
although it had little, if any, effect on MT-1a or MT-2a mRNAs.
Although NAC has been commonly used to implicate ROS in
signaling pathways [69], it has other effects that complicate
the interpretation of the data. For example, it can act directly
on TGF-β leading to its inactivation [35]. Thus, the inhibition
of the vitreous effect could be due to inhibition of the TGF-β-
dependent component as well as a ROS-dependent compo-
nent. Because of this, other ROS scavengers and quenchers
were used, including catalase (which breaks down hydrogen
peroxide), taurine [70], and DMSO [71]. All of these reduced
vitreous-mediated induction of HO-1 expression and supported
the importance of the signaling role of ROS, although none of
them showed as great an effect as NAC; this would be consis-
tent with NAC suppressing other pathway(s) besides those
mediated via ROS.
TGF-β classically signals via smads, which bind to the
promoters of their target genes [72]. However, other signaling
pathways via ERK, p38 MAPK, and JNK are also important
[36,41]. Although these MAPK pathways often transmit
growth factor, extracellular matrix and cytokine signals, re-
spectively, there is cross-talk between them that is particu-
larly evident between the p38 and JNK pathways [73]. These
signaling pathways participate in the control of HO-1 expres-
sion in a number of cell systems [7]. In human RPE cells, the
PI3 kinase and MEK 44/42 pathways appear not to be involved
in the control of HO-1 expression by vitreous, as judged by
the lack of effect of LY294002 and PD98059, respectively,
whereas inhibitors of the JNK and the p38MAPK pathways
(SP600125 and SB203580) reduced vitreous-meditated HO-
1 mRNA expression. P38 MAPK can be activated by TGF-β
[74-76] and mediates some of its effects in a smad-indepen-
dent [75], AP-1-dependent manner [76,77]. JNK can also be
activated by TGF-β [76] and regulates the activity of AP-1
transcription factor complexes [78] (as well as smads [79]) by
phosphorylation. These data suggest the possibility that vitre-
ous and TGF-β might induce their anti-oxidant responses via
AP-1 activation.
AP-1 complexes consist of homo- or hetero dimers of
basic leucine zipper family members, including c-jun, c-fos,
and several other proteins [80,81]. We found vitreous caused
an increase in AP-1 site binding activity, and that part of this
was associated with complexes containing c-fos. Vitreous also
caused an increase in c-fos mRNA and protein expression and
translocation of c-fos to the nucleus. This is important because
AP-1 activity has been implicated in expression of HO-1 and
MTs. The promoter region of the HO-1 gene has many tran-
scription factor binding sites, including those for AP-1, lead-
ing to complex regulation [7,82]. MT-1 [83] and MT-2 [84-
86] promoters also contain AP-1 binding sites. Studies of en-
hanced HO-1 and MT expression as a result of oxidative stress
and inflammation often implicate AP-1 transcription factor
activation [16,44,87] and, although the promoter elements that
control TGF-β-mediated HO-1 induction have not been iden-
tified, AP-1 activation has been implicated in the induction of
several other TGF-β-responsive genes [88,89].
In summary, our data show that vitreous can initiate an
anti-oxidant response in human RPE cells, as exemplified by
an increase in HO-1 and MT expression. It is likely that TGF-
β and ROS signaling participate in the induction of HO-1 by
vitreous, and that the p38 MAPK and JNK pathways are in-
volved. Both p38 and JNK target AP-1 transcription factor
complexes and, since AP-1 is important to the regulation of
HO-1 and MT in other systems, it is possible it is involved in
the vitreous-mediated response. In contrast, the pathway for
MT induction by vitreous is quite different and does not uti-
lize TGF-β or ROS signaling and does not involve p38 or JNK
signaling.
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